İstanbul Journal of Pharmacy

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IstanbulJPharm.2020.0049   IUP :10.26650/IstanbulJPharm.2020.0049    Full Text (PDF)

Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population

Zuhal Uçkun Şahinoğulları

Background and Aims: The polymorphisms in genes encoding xenobiotic-metabolizing enzymes may change the metabolic activation of various xenobiotics and therefore may affect individuals’ susceptibility to xenobiotics-induced toxic effects. Cytochrome P450 2A13 (CYP2A13) is an important CYP enzyme predominantly expressed in the human respiratory tract. CYP2A13 metabolizes the xenobiotics and bioactivation of several carcinogens. The present study aimed to determine the allele and genotype frequencies of CYP2A13 3375C>T polymorphism in a Turkish population and also to compare the obtained results with those of various populations. Methods: CYP2A13 3375C>T polymorphism was determined in 93 healthy Turkish individuals using the polymerase chain reaction-restriction fragment length method. Results: The frequencies of CC, CT and TT genotypes were 89.2%, 9.7% and 1.1%, respectively. The frequencies of C and T alleles were 94.1% and 5.9%, respectively. The genotype frequencies did not deviate from the Hardy-Weinberg equilibrium. Significant differences were observed when comparing the results found with those of various populations, especially those of populations with black ancestry (excluding Tunisian). Conclusion: This study can provide valuable data for further studies investigating the role of this polymorphism concerning the susceptibility to xenobiotics-induced toxic effects, including cancer, and may be used as a control group for such studies and also may contribute to toxicogenetic and epidemiological studies.

Keywords: CYP2A13 3375C>T, genetic polymorphism, Arg257Cys, Turkish population

PDF View

References

  • • Alzahrani, A. M., & Rajendran, P. (2020). The multifarious link between cytochrome P450s and cancer. Oxidative Medicine and Cellular Longevity, 2020:3028387. google scholar
  • • Cauffiez, C., Pottier, N., Tournel, G., Lo-Guidice, J. M., Allorge, D., Chevalier, D., Migot-Nabias, F., Kenani, A., & Broly, F. (2005). CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica, 35(7), 661−669. google scholar
  • • Cheng, X. Y., Chen, G. L., Zhang, W. X., Zhou, G., Wang, D., & Zhou, H. H. (2004). Arg257Cys polymorphism of CYP2A13 in a Chinese population. Clinica Chimica Acta, 343(1-2), 213−216. google scholar
  • • D‘Agostino, J., Zhang, X., Wu, H., Ling, G., Wang, S., Zhang, Q.Y., Liu, F., & Ding, X. (2008). Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug Metabolism and Disposition, 36(11), 2316−2323. google scholar
  • • Elfaki, I., Mir, R., Almutairi, F. M., & Duhier, F. M. A. (2018). Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis. Asian Pacific Journal of Cancer Prevention, 19(8), 2057−2070. google scholar
  • • Fujieda, M., Yamazaki, H., Kiyotani, K., Muroi, A., Kunitoh, H., Dosaka- Akita, H., Sawamura, Y., & Kamataki, T. (2003). Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. Drug Metabolism and Pharmacokinetics, 18(1), 86−90. google scholar
  • • Fukami, T., Nakajima, M., Matsumoto, I., Zen, Y., Oda, M., & Yokoi, T. (2010). Immunohistochemical analysis of CYP2A13 in various types of human lung cancers. Cancer Science, 101(4), 1024−1028. google scholar
  • • Fukami, T., Nakajima, M., Sakai, H., Katoh, M., & Yokoi, T. (2007). CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Drug Metabolism and Disposition, 35(3), 335–339. google scholar
  • • Herr, D., Bettendorf, H., Denschlag, D., Keck, C., & Pietrowski, D. (2006). Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma. Archives of Gynecology and Obstetrics, 274(6), 367−371. google scholar
  • • http-1: https://www.pharmvar.org/gene/CYP2A13. Accessed 10.04.2020. • http-2: https://www.internationalgenome.org/1000-genomesbrowsers/. Accessed 03.04.2020. google scholar
  • • Jiang, J. H., Jia, W. H., Chen, H. K., Feng, B. J., Qin, H. D., Pan, Z. G., Shen, G. P., Huang, L. X., Feng, Q. S., Chen, L. Z., Lin, D. X., & Zeng, Y. X. (2004). Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population. Journal of Translational Medicine, 2(1), 24. google scholar
  • • Kim, V., Yeom, S., Lee, Y., Park, H. G., Cho, M. A., Kim, H., & Kim, D. (2018). In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10. Journal of Toxicology and Environmental Health. Part A, 81(12), 493−501. google scholar
  • • Korytina, G., Kochetova, O., Akhmadishina, L., Viktorova, E., & Victorova, T. (2012). Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia. Balkan Medical Journal, 29(3), 252−260. google scholar
  • • Kumondai, M., Hosono, H., Orikasa, K., Arai, Y., Arai, T., Sugimura, H., Ozono, S., Sugiyama, T., Takayama, T., Sasaki, T., Hirasawa, N., & Hiratsuka, M. (2016). CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers. Biological & Pharmaceutical Bulletin, 39(10), 1683−1686. google scholar
  • • Schlicht, K. E., Michno, N., Smith, B. D., Scott, E. E., & Murphy, S. E. (2007). Functional characterization of CYP2A13 polymorphisms. Xenobiotica, 37(12), 1439−1449. google scholar
  • • Sharma, R., Ahuja, M., Panda, N., & Khullar, M. (2010). Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral Diseases, 16(8), 760−768. google scholar
  • • Song, D. K., Xing, D. L., Zhang, L. R., Li, Z. X., Liu, J., & Qiao, B. P. (2009). Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detection and Prevention, 32(5-6), 416−423. google scholar
  • • Su, T., Bao, Z., Zhang, Q. Y., Smith, T. J., Hong, J. Y., & Ding, X. (2000). Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone. Cancer Research, 60(18), 5074−5079. google scholar
  • • Tamaki, Y., Honda, M., Muroi, Y., Arai, T., Sugimura, H., Matsubara, Y., Kanno, S., Ishikawa, M., Hirasawa, N., & Hiratsuka, M. (2011a) Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals. Drug Metabolism and Pharmacokinetics, 26(5), 544–547. google scholar
  • • Tamaki, Y., Arai, T., Sugimura, H., Sasaki, T., Honda, M., Muroi, Y., Matsubara, Y., Kanno, S., Ishikawa, M., Hirasawa, N., & Hiratsuka, M. (2011b) Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metabolism and Pharmacokinetics, 26(5), 516−522. google scholar
  • • Timofeeva, M. N., Kropp, S., Sauter, W., Beckmann, L., Rosenberger, A., Illig, T., Jäger, B., Mittelstrass, K., Dienemann, H.; LUCY-Consortium, Bartsch, H., Bickeböller, H., Chang-Claude, J. C., Risch, A., & Wichmann, H. E. (2009). CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis, 30(7), 1161−1169. google scholar
  • • Uckun Sahinogullari, Z. (2020). Genetic polymorphism of CYP2C8* 4 in a healthy Turkish population. Medicine Science, 9(2), 314−319. google scholar
  • • Wang, S. L., He, X. Y., Shen, J., Wang, J. S., & Hong, J. Y. (2006). The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant. Toxicological Sciences, 94(1), 38−45. google scholar
  • • Wang, H., Tan, W., Hao, B., Miao, X., Zhou, G., He, F., & Lin, D. (2003). Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Research, 63(22), 8057–8061. google scholar
  • • Zhang, X., Su, T., Zhang, Q. Y., Gu, J., Caggana, M., Li, H., & Ding, X. (2002). Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. Journal of Pharmacology and Experimental Therapeutics, 302(2), 416−423. google scholar
  • • Zhou, S. F., Liu, J. P., & Chowbay, B. (2009). Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews, 41(2), 89−295. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Uçkun Şahinoğulları, Z. (2020). Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population. İstanbul Journal of Pharmacy, 50(3), 181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049


AMA

Uçkun Şahinoğulları Z. Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population. İstanbul Journal of Pharmacy. 2020;50(3):181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049


ABNT

Uçkun Şahinoğulları, Z. Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population. İstanbul Journal of Pharmacy, [Publisher Location], v. 50, n. 3, p. 181-187, 2020.


Chicago: Author-Date Style

Uçkun Şahinoğulları, Zuhal,. 2020. “Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population.” İstanbul Journal of Pharmacy 50, no. 3: 181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049


Chicago: Humanities Style

Uçkun Şahinoğulları, Zuhal,. “Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population.” İstanbul Journal of Pharmacy 50, no. 3 (Apr. 2024): 181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049


Harvard: Australian Style

Uçkun Şahinoğulları, Z 2020, 'Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population', İstanbul Journal of Pharmacy, vol. 50, no. 3, pp. 181-187, viewed 20 Apr. 2024, https://doi.org/10.26650/IstanbulJPharm.2020.0049


Harvard: Author-Date Style

Uçkun Şahinoğulları, Z. (2020) ‘Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population’, İstanbul Journal of Pharmacy, 50(3), pp. 181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049 (20 Apr. 2024).


MLA

Uçkun Şahinoğulları, Zuhal,. “Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population.” İstanbul Journal of Pharmacy, vol. 50, no. 3, 2020, pp. 181-187. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2020.0049


Vancouver

Uçkun Şahinoğulları Z. Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population. İstanbul Journal of Pharmacy [Internet]. 20 Apr. 2024 [cited 20 Apr. 2024];50(3):181-187. Available from: https://doi.org/10.26650/IstanbulJPharm.2020.0049 doi: 10.26650/IstanbulJPharm.2020.0049


ISNAD

Uçkun Şahinoğulları, Zuhal. “Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population”. İstanbul Journal of Pharmacy 50/3 (Apr. 2024): 181-187. https://doi.org/10.26650/IstanbulJPharm.2020.0049



TIMELINE


Submitted16.05.2020
Accepted30.07.2020
Published Online31.12.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.